Exogenous Ketones in Type 2 Diabetes

NACompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

January 15, 2020

Primary Completion Date

May 20, 2022

Study Completion Date

May 20, 2022

Conditions
KetosisType 2 Diabetes
Interventions
DIETARY_SUPPLEMENT

Ketone monoester

Acute ingestion of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate prior to assessment of outcomes.

DIETARY_SUPPLEMENT

Placebo

Acute ingestion of taste-matched placebo prior to assessment of outcomes.

Trial Locations (1)

V1V 1V7

University of British Columbia, Okanagan, Kelowna

All Listed Sponsors
lead

University of British Columbia

OTHER

NCT04194450 - Exogenous Ketones in Type 2 Diabetes | Biotech Hunter | Biotech Hunter